MX2021011695A - Allogenic implants for treating cartilage injuries. - Google Patents
Allogenic implants for treating cartilage injuries.Info
- Publication number
- MX2021011695A MX2021011695A MX2021011695A MX2021011695A MX2021011695A MX 2021011695 A MX2021011695 A MX 2021011695A MX 2021011695 A MX2021011695 A MX 2021011695A MX 2021011695 A MX2021011695 A MX 2021011695A MX 2021011695 A MX2021011695 A MX 2021011695A
- Authority
- MX
- Mexico
- Prior art keywords
- cartilage
- injury
- relates
- cartilage injuries
- treating cartilage
- Prior art date
Links
- 206010007710 Cartilage injury Diseases 0.000 title abstract 3
- 239000007943 implant Substances 0.000 title 1
- 210000000845 cartilage Anatomy 0.000 abstract 2
- 210000001612 chondrocyte Anatomy 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000000735 allogeneic effect Effects 0.000 abstract 1
- 210000001188 articular cartilage Anatomy 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Cardiology (AREA)
- Composite Materials (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a graft or construct, including chondrocytes isolated from the cartilage of young donors (<20 years), seeded on a three-dimensional membrane. It consists of one of the main chondrogenesis-promoting substances (hyaluronic acid) in high densities (1x106) with autologous serum, sealed with fibrin glue, healing a cartilage injury, forming tissue of higher durability, lowering costs and risks. Also, it relates to a process for treating articular cartilage injuries by implanting allogeneic chondrocyte grafts, thus generating and repairing the cartilage of the injury.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2021011695A MX2021011695A (en) | 2021-09-24 | 2021-09-24 | Allogenic implants for treating cartilage injuries. |
| PCT/MX2022/050017 WO2023048552A1 (en) | 2021-09-24 | 2022-03-11 | Allogenic implants for the treatment of cartilage injuries |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2021011695A MX2021011695A (en) | 2021-09-24 | 2021-09-24 | Allogenic implants for treating cartilage injuries. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021011695A true MX2021011695A (en) | 2022-03-03 |
Family
ID=85720971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021011695A MX2021011695A (en) | 2021-09-24 | 2021-09-24 | Allogenic implants for treating cartilage injuries. |
Country Status (2)
| Country | Link |
|---|---|
| MX (1) | MX2021011695A (en) |
| WO (1) | WO2023048552A1 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2367694T3 (en) * | 2003-12-11 | 2011-11-07 | Isto Technologies Inc. | PARTICULATED CARTRIDGE SYSTEM. |
-
2021
- 2021-09-24 MX MX2021011695A patent/MX2021011695A/en unknown
-
2022
- 2022-03-11 WO PCT/MX2022/050017 patent/WO2023048552A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023048552A1 (en) | 2023-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Iaquinta et al. | Innovative biomaterials for bone regrowth | |
| Steinert et al. | Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives | |
| Guerado et al. | Challenges of bone tissue engineering in orthopaedic patients | |
| Yamada et al. | Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold | |
| Sims et al. | Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes | |
| Veronesi et al. | Adipose‐derived mesenchymal stem cells for cartilage tissue engineering: state‐of‐the‐art in in vivo studies | |
| Griffin et al. | Exploring the application of mesenchymal stem cells in bone repair and regeneration | |
| Lee et al. | ADSC-based cell therapies for musculoskeletal disorders: a review of recent clinical trials | |
| Khaled et al. | Tissue engineering for bone production-stem cells, gene therapy and scaffolds | |
| Kasir et al. | Regenerative engineering of cartilage using adipose-derived stem cells | |
| Kiernan et al. | Endochondral ossification: recapitulating bone development for bone defect repair | |
| Pigeot et al. | Manufacturing of human tissues as off‐the‐shelf grafts programmed to induce regeneration | |
| Chimutengwende-Gordon et al. | Advances in the use of stem cells and tissue engineering applications in bone repair | |
| US11771804B2 (en) | Bone grafts including osteogenic stem cells, and methods relating to the same | |
| Zellner et al. | Are applied growth factors able to mimic the positive effects of mesenchymal stem cells on the regeneration of meniscus in the avascular zone? | |
| CA2563082A1 (en) | Cartilage repair mixture containing allograft chondrocytes | |
| Browe et al. | Glyoxal cross‐linking of solubilized extracellular matrix to produce highly porous, elastic, and chondro‐permissive scaffolds for orthopedic tissue engineering | |
| CN101084026A (en) | Poly (ethylene glycol) - diacrylate (pegda) - crosslinked comprising adipogenic mesenchymal stem cells | |
| Pleumeekers et al. | Cartilage regeneration in the head and neck area: combination of ear or nasal chondrocytes and mesenchymal stem cells improves cartilage production | |
| Krasilnikova et al. | Intraoperative creation of tissue-engineered grafts with minimally manipulated cells: new concept of bone tissue engineering in situ | |
| US9486483B2 (en) | Bone grafts including osteogenic stem cells, and methods relating to the same | |
| Chen et al. | 3D composite engineered using supercritical CO2 decellularized porcine cartilage scaffold, chondrocytes, and PRP: Role in articular cartilage regeneration | |
| Lee et al. | A novel 3D histotypic cartilage construct engineered by supercritical carbon dioxide decellularized porcine nasal cartilage graft and chondrocytes exhibited chondrogenic capability in vitro | |
| Zhang et al. | Mesenchymal stem cell-derived extracellular matrix (mECM): a bioactive and versatile scaffold for musculoskeletal tissue engineering | |
| EP2259804B1 (en) | Method for producing an implantable bone composition |